| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
333 |
312 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,316 |
1,009 |
$5K |
| 80053 |
Comprehensive metabolic panel |
1,239 |
843 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
63 |
63 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
29 |
29 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
37 |
24 |
$824.20 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13 |
13 |
$570.52 |
| 81025 |
|
128 |
118 |
$449.17 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
285 |
149 |
$396.48 |
| 81001 |
|
180 |
161 |
$250.06 |
| 84484 |
|
83 |
58 |
$124.56 |
| 83605 |
|
70 |
40 |
$105.07 |
| 83690 |
|
112 |
99 |
$67.83 |
| 80306 |
|
13 |
13 |
$59.43 |
| 82077 |
|
131 |
121 |
$0.00 |
| 83735 |
|
92 |
38 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
42 |
42 |
$0.00 |